Annual Total Long Term Liabilities
$43.17 M
+$43.17 M+100.00%
31 December 2023
Summary:
Cara Therapeutics annual total long term liabilities is currently $43.17 million, with the most recent change of +$43.17 million (+100.00%) on 31 December 2023. During the last 3 years, it has risen by +$39.49 million (+1075.25%). CARA annual total long term liabilities is now at all-time high.CARA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$40.58 M
-$6.41 M-13.65%
30 September 2024
Summary:
Cara Therapeutics quarterly total long term liabilities is currently $40.58 million, with the most recent change of -$6.41 million (-13.65%) on 30 September 2024. Over the past year, it has increased by +$33.77 million (+495.50%). CARA quarterly long term liabilities is now -13.65% below its all-time high of $47.00 million, reached on 30 June 2024.CARA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | +495.5% |
| 3 y3 years | +1075.3% | +1610.2% |
| 5 y5 years | +157.8% | +1026.7% |
CARA Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | -13.7% | ||
| 5 y | 5 years | at high | -13.7% | ||
| alltime | all time | at high | -13.7% |
Cara Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $40.58 M(-13.6%) |
| June 2024 | - | $47.00 M(+4.0%) |
| Mar 2024 | - | $45.20 M(+4.7%) |
| Dec 2023 | $43.17 M(>+9900.0%) | $43.17 M(+533.4%) |
| Sept 2023 | - | $6.82 M(>+9900.0%) |
| June 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2022 | - | $497.00 K(-49.4%) |
| June 2022 | - | $983.00 K(-32.4%) |
| Mar 2022 | - | $1.46 M(-24.1%) |
| Dec 2021 | $1.92 M(-47.8%) | $1.92 M(-19.2%) |
| Sept 2021 | - | $2.37 M(-15.8%) |
| June 2021 | - | $2.82 M(-13.3%) |
| Mar 2021 | - | $3.25 M(-11.5%) |
| Dec 2020 | $3.67 M(+9.6%) | $3.67 M(+36.5%) |
| Sept 2020 | - | $2.69 M(-9.1%) |
| June 2020 | - | $2.96 M(-4.4%) |
| Mar 2020 | - | $3.10 M(-7.6%) |
| Dec 2019 | $3.35 M(-80.0%) | $3.35 M(-6.9%) |
| Sept 2019 | - | $3.60 M(-63.7%) |
| June 2019 | - | $9.93 M(-27.3%) |
| Mar 2019 | - | $13.66 M(-18.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $16.75 M(+874.7%) | $16.75 M(-16.0%) |
| Sept 2018 | - | $19.93 M(-37.7%) |
| June 2018 | - | $31.99 M(+1830.8%) |
| Mar 2018 | - | $1.66 M(-3.6%) |
| Dec 2017 | $1.72 M(+9.4%) | $1.72 M(+1.0%) |
| Sept 2017 | - | $1.70 M(+8.8%) |
| June 2017 | - | $1.56 M(+3.0%) |
| Mar 2017 | - | $1.52 M(-3.3%) |
| Dec 2016 | $1.57 M(+168.4%) | $1.57 M(+3.0%) |
| Sept 2016 | - | $1.52 M(+18.3%) |
| June 2016 | - | $1.29 M(+29.3%) |
| Mar 2016 | - | $997.00 K(+70.4%) |
| Dec 2015 | $585.00 K(-33.1%) | $585.00 K(-11.4%) |
| Sept 2015 | - | $660.00 K(-9.8%) |
| June 2015 | - | $732.00 K(-8.8%) |
| Mar 2015 | - | $803.00 K(-8.1%) |
| Dec 2014 | $874.00 K(-23.3%) | $874.00 K(-7.4%) |
| Sept 2014 | - | $944.00 K(-6.4%) |
| June 2014 | - | $1.01 M(-6.1%) |
| Mar 2014 | - | $1.07 M(-5.7%) |
| Dec 2013 | $1.14 M(-19.3%) | $1.14 M(-5.2%) |
| Sept 2013 | - | $1.20 M(-14.9%) |
| Dec 2012 | $1.41 M(-14.5%) | $1.41 M |
| Dec 2011 | $1.65 M | - |
FAQ
- What is Cara Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Cara Therapeutics?
- What is Cara Therapeutics annual total long term liabilities year-on-year change?
- What is Cara Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Cara Therapeutics?
- What is Cara Therapeutics quarterly long term liabilities year-on-year change?
What is Cara Therapeutics annual total long term liabilities?
The current annual total long term liabilities of CARA is $43.17 M
What is the all time high annual total long term liabilities for Cara Therapeutics?
Cara Therapeutics all-time high annual total long term liabilities is $43.17 M
What is Cara Therapeutics annual total long term liabilities year-on-year change?
Over the past year, CARA annual total long term liabilities has changed by +$43.17 M (+100.00%)
What is Cara Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of CARA is $40.58 M
What is the all time high quarterly long term liabilities for Cara Therapeutics?
Cara Therapeutics all-time high quarterly total long term liabilities is $47.00 M
What is Cara Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, CARA quarterly total long term liabilities has changed by +$33.77 M (+495.50%)